CRBU
Price
$2.37
Change
-$0.11 (-4.44%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
220.42M
18 days until earnings call
PRME
Price
$4.34
Change
-$0.30 (-6.47%)
Updated
Jul 24, 04:59 PM (EDT)
Capitalization
624.06M
13 days until earnings call
Interact to see
Advertisement

CRBU vs PRME

Header iconCRBU vs PRME Comparison
Open Charts CRBU vs PRMEBanner chart's image
Caribou Biosciences
Price$2.37
Change-$0.11 (-4.44%)
Volume$13.49K
Capitalization220.42M
Prime Medicine
Price$4.34
Change-$0.30 (-6.47%)
Volume$67.2K
Capitalization624.06M
CRBU vs PRME Comparison Chart in %
Loading...
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRBU vs. PRME commentary
Jul 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRBU is a Buy and PRME is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 25, 2025
Stock price -- (CRBU: $2.48 vs. PRME: $4.64)
Brand notoriety: CRBU and PRME are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRBU: 182% vs. PRME: 125%
Market capitalization -- CRBU: $230.65M vs. PRME: $624.06M
CRBU [@Biotechnology] is valued at $230.65M. PRME’s [@Biotechnology] market capitalization is $624.06M. The market cap for tickers in the [@Biotechnology] industry ranges from $295.06B to $0. The average market capitalization across the [@Biotechnology] industry is $2.5B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRBU’s FA Score shows that 1 FA rating(s) are green whilePRME’s FA Score has 0 green FA rating(s).

  • CRBU’s FA Score: 1 green, 4 red.
  • PRME’s FA Score: 0 green, 5 red.
According to our system of comparison, CRBU is a better buy in the long-term than PRME.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRBU’s TA Score shows that 3 TA indicator(s) are bullish while PRME’s TA Score has 2 bullish TA indicator(s).

  • CRBU’s TA Score: 3 bullish, 4 bearish.
  • PRME’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, CRBU is a better buy in the short-term than PRME.

Price Growth

CRBU (@Biotechnology) experienced а +35.52% price change this week, while PRME (@Biotechnology) price change was +14.85% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.88%. For the same industry, the average monthly price growth was +18.15%, and the average quarterly price growth was +28.82%.

Reported Earning Dates

CRBU is expected to report earnings on Nov 11, 2025.

PRME is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+5.88% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRME($624M) has a higher market cap than CRBU($220M). PRME YTD gains are higher at: 58.904 vs. CRBU (49.057). CRBU has higher annual earnings (EBITDA): -159.14M vs. PRME (-200M). CRBU has more cash in the bank: 208M vs. PRME (144M). CRBU has less debt than PRME: CRBU (26.2M) vs PRME (121M). CRBU has higher revenues than PRME: CRBU (9.92M) vs PRME (3.85M).
CRBUPRMECRBU / PRME
Capitalization220M624M35%
EBITDA-159.14M-200M80%
Gain YTD49.05758.90483%
P/E RatioN/AN/A-
Revenue9.92M3.85M258%
Total Cash208M144M144%
Total Debt26.2M121M22%
FUNDAMENTALS RATINGS
PRME: Fundamental Ratings
PRME
OUTLOOK RATING
1..100
26
VALUATION
overvalued / fair valued / undervalued
1..100
62
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRBUPRME
RSI
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
N/A
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 4 days ago
78%
Declines
ODDS (%)
Bearish Trend 14 days ago
89%
Bearish Trend 9 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Interact to see
Advertisement
CRBU
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PRME
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JIUCX17.340.38
+2.24%
JPMorgan Developed International Value C
RSEIX14.890.20
+1.36%
Royce Small-Cap Special Equity Instl
RYMKX55.59N/A
N/A
Rydex Russell 2000 1.5x Strategy H
FGEAX26.81N/A
N/A
Fidelity Advisor Glbl Capital Apprec A
JDISX16.37N/A
N/A
JHancock Disciplined Value Intl R2

CRBU and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRBU has been loosely correlated with CRSP. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if CRBU jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRBU
1D Price
Change %
CRBU100%
-4.44%
CRSP - CRBU
63%
Loosely correlated
-3.05%
BEAM - CRBU
56%
Loosely correlated
-5.46%
RXRX - CRBU
54%
Loosely correlated
-2.64%
CCCC - CRBU
54%
Loosely correlated
-5.37%
NTLA - CRBU
53%
Loosely correlated
-10.25%
More